Abstract
Exposure to parasitic flatworms causing schistosomiasis is a complex set of human-environment interactions. Yet, exposure often is equated to current infection. Here we studied risk factors and population patterns of exposure (water contact) within the SchistoTrack Cohort for 2867 individuals aged 5-90 years in Eastern and Western Uganda. Households within 0.34 km of waterbodies accounted for 80% of all water contact. We found a 15-year gap between population-level peak in water contact (age 30) and infection (age 15) with practically no correlation (ρ=0.03) of individual-level water contact and current infection. Bayesian selection for 30 biosocial variables was used to separately predict water contact and current infection. Water contact was positively associated with older age, female gender, fishing occupation, lack of site contamination, unsafe village drinking water, number of sites and type (beach/pond), lower village-level infection prevalence, and fewer village roads. Among these variables, only older age and fishing were positively, though inconsistently associated with infection status/intensity. Water, sanitation, and hygiene influenced water contact but not infection. Our findings highlight that exposure was highly focal and at-risk groups for exposure and infection were different. Precision mapping and targeted treatment/interventions directly focused on exposure are needed to save medicines and reduce transmission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A DPhil scholarship was awarded from the Nuffield Department of Population Health (NDPH) to Fabian Reitzug. Grants from the Wellcome Trust Institutional Strategic Support Fund (204826/Z/16/Z), NDPH Pump Priming Fund, John Fell Fund, Robertson Foundation Fellowship, and UKRI EPSRC Award (EP/X021793/1) were awarded to Goylette F. Chami.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data collection and use were reviewed and approved by Oxford Tropical Research Ethics Committee (OxTREC 509-21), Vector Control Division Research Ethics Committee of the Uganda Ministry of Health (VCDREC146), and Uganda National Council of Science and Technology (UNCST HS 1664ES).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
Data is not publicly available due to data protection and ethics restrictions related to the ongoing nature of the SchistoTrack Cohort and easily identifiable nature of the participants.
